Gerresheimer, Faces

Gerresheimer Faces Deepening Accounting Crisis and Regulatory Scrutiny

11.03.2026 - 04:35:38 | boerse-global.de

Gerresheimer's 2025 annual report is delayed, risking SDAX removal and facing a BaFin investigation into its accounting. Management seeks lender waivers to avoid defaults.

Gerresheimer Faces Deepening Accounting Crisis and Regulatory Scrutiny - Foto: über boerse-global.de
Gerresheimer Faces Deepening Accounting Crisis and Regulatory Scrutiny - Foto: über boerse-global.de

The financial reporting issues at packaging specialist Gerresheimer have intensified, with the company now unable to publish its audited 2025 annual report on schedule. This delay, stemming from an extended external audit, is triggering a cascade of serious consequences, including potential removal from a key German stock index and heightened regulatory oversight.

Regulatory Pressure and Index Exclusion Threat

At the heart of the crisis is a prolonged examination by a second external auditing firm, which is scrutinizing business transactions from 2024 and 2025. The board now aims to present the certified annual and group financial statements by June 2026—a full three months past the original deadline. This postponement forces the rescheduling of both the Q1 2026 quarterly report and the annual general meeting.

A particularly damaging outcome now appears likely: exclusion from the SDAX index. Deutsche Börse requires timely financial statements, making Gerresheimer's removal a probable event. Such a move would exacerbate the already severe selling pressure on its shares, which have plummeted approximately 79% over the last twelve months.

Simultaneously, German financial regulator BaFin is turning up the heat. Since early March, it has been reviewing the group's interim financial report as of May 31, 2025. The probe focuses on three specific areas: the financing of the Bormioli Pharma acquisition, potential asset impairments, and revenue recognition related to "bill-and-hold" agreements. In such transactions, revenue is booked before goods physically reach the customer—an accounting practice that has precipitated significant balance sheet problems at other companies in the past.

Should investors sell immediately? Or is it worth buying Gerresheimer?

Management Seeks Lender Waivers

In a bid to avoid technical defaults on its existing financing agreements, Gerresheimer's management has initiated talks with its creditors. The objective is to secure a formal extension for the submission deadlines of the audited financial reports. The necessity of these negotiations underscores the gravity of the company's situation.

For investors, the convergence of the special audit, the BaFin investigation, and the lender discussions creates profound uncertainty. The underlying accounting matters must be fully resolved before the company's operational performance can be reliably assessed. Clarity is not expected until the financial statements are finally released in June 2026 at the earliest.

Ad

Gerresheimer Stock: New Analysis - 11 March

Fresh Gerresheimer information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Gerresheimer analysis...

So schätzen die Börsenprofis Gerresheimer Aktien ein!

<b>So schätzen die Börsenprofis  Gerresheimer Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
en | DE000A0LD6E6 | GERRESHEIMER | boerse | 68657709 |